There have been several updates to the website this month.
The interaction checker has seen the addition of nine new comedications (shown below) and the removal of one comedication (simeprevir):
- Busulfan (Cancer Therapies)
- Copanlisib (Cancer Therapies)
- Elagolix (Other)
- Moexipril (Hypertension / Heart Failure Agents)
- Repotrectinib (Cancer Therapies)
- Rezafungin (Antifungals)
- Romidepsin (Cancer Therapies)
- Ropivacaine (Anaesthetics and Muscle Relaxants)
- Thiotepa (Cancer Therapies)
There have also been some changes in the Prescribing Resource sections with one new resource and five updated resources.
- New - Interactions with lenacapavir
- Updated - Interactions with hormone therapy for gender affirmation
- Updated - ARVs for patients with swallowing difficulties
- Updated - ARVs and food requirements
- Updated - Dosing of ARVs for patients with renal impairment
- Updated - Interactions with FTC/TDF PrEP and long-term use medications
All these resources (and many others) can be found under the Prescribing and Dosing Guidance heading in the Prescribing Resources section of the website.
